Cancer Biomarkers

Cancer biomarkers serve as crucial compasses in the realm of cancer research, providing pivotal clues into diagnosis, prognosis, and treatment efficacy. These biological indicators encompass a diverse array of molecules—ranging from proteins to genes—found in bodily fluids, tissues, or blood. Their analysis enables the detection of cancer at earlier stages, prognostication of disease trajectory, and customization of treatment plans tailored to individual patients. Recent strides in technology, such as genomic sequencing and liquid biopsies, have significantly augmented the precision and scope of biomarker identification. Moreover, ongoing investigations are dedicated to unearthing novel biomarkers capable of revolutionizing early detection methods and enhancing patient outcomes, thus charting a promising course toward personalized cancer management.